(continued)
- Caplyta (lumateperone)
- Secuado (asenapine)
- Rybelsus (semaglutide)
- Reblozyl (luspatercept)
- Asceniv (Immune Globulin Intravenous, Human-slra)
- Brukinsa (zanubrutinib)
- Xembify (Immune Globulin Subcutaneous, Human-klhw)
- Drospirenone (Slynd)
- Cutaquig (immune globulin subcutaneous, human-hipp)
- Polivy (polatuzumab vedotin-piiq)
- Dovato (dolutegravir/lamivudine)
- Panzyga (immune globulin intravenous, human-ifas)
- Levoleucovorin (Fusilev, Khapzory)
- Perseris (risperidone)
- Doptelet (avatrombopag)
- Ozempic (semaglutide)
- Calquence (acalabrutinib)
- Austedo (deutetrabenazine)
- Ingrezza (valbenazine)
- Cuvitru (immune globulin subcutaneous, human)
- Soliqua (insulin glargine/lixisenatide)
- Menthol topical (Biofreeze, Icy Hot, and others)
- Taltz (ixekizumab)
- Cinqair (reslizumab)
- Venclexta (venetoclax)
- Nuplazid (pimavanserin)
- Amphetamine (Adzenys XR-ODT, Adzenys XR-ODTXR, and others)
- Addyi (flibanserin)
- Vraylar (cariprazine)
- Aristada (aripiprazole)
- Austedo: Regaining Control Over Uncontrolled Movements in Huntington’s and Tardive Dyskinesia
- Managing Rheumatoid Arthritis With Xeljanz
- How Does Rybelsus Control Type 2 Diabetes?
- Navigating Bipolar I With Vraylar
- Managing Major Depressive Disorder With Vraylar
- Preventing Heart Failure Complications With Entresto
- How Airsupra Works for Asthma